GHK-Cu Liposomes in a Mouse Scald-Wound Model
Researchers encapsulated GHK-Cu in liposomes and evaluated the formulation in endothelial cells and a mouse scald-wound model.
Study design
The study assessed human umbilical-vein endothelial-cell proliferation and related protein expression before comparing liposomal and free GHK-Cu in burned mouse skin using wound timing and tissue markers.
What the researchers reported
The liposomal formulation increased endothelial-cell proliferation and was associated with stronger angiogenesis-related signals than free GHK-Cu in mice. The authors reported wound closure by day 14 in the experimental model.
What this result does not establish
This study tested a particular liposomal formulation, not GHK-Cu in every form. Mouse wound closure and cell-marker changes cannot establish human wound-healing outcomes or product equivalence.
This article summarizes one published study about GHK-Cu. It does not establish clinical efficacy, general safety, regulatory approval or suitability for human use. Findings should be interpreted within the model, methods and limitations of the original paper.
Related research material
Review the corresponding catalogue listing, labelled amount and available documentation. The study may use a different formulation or experimental preparation; it does not verify our product, its batch or suitability for human use.
Our Approach
Evidence before assumption.
TAM Global Research focuses on transparent documentation, careful scientific interpretation and clear distinction between what available evidence supports and what requires further verification.
Explore our quality standards